デフォルト表紙
市場調査レポート
商品コード
1481123

合成生物工学の世界市場

Synthetic Orthobiologics

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 93 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.74円
合成生物工学の世界市場
出版日: 2024年05月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

合成生物工学の世界市場は2030年までに14億米ドルに達する見込み

2023年に9億8,060万米ドルと推定される合成生物工学の世界市場は、分析期間2023~2030年にCAGR 5.6%で成長し、2030年には14億米ドルに達すると予測されます。

このレポートで分析したセグメントの1つである変形性関節症&退行性関節炎アプリケーションは、CAGR 5.7%を占め、分析期間終了までに4億5,620万米ドルに達すると予測されます。骨折回復アプリケーション分野の成長は、今後7年間のCAGRが5.8%と推定されています。

米国市場は2億5,760万米ドル、中国はCAGR 8.4%で成長すると予測

米国の合成生物工学市場は、2023年には2億5,760万米ドルになると推定されます。世界第2位の経済大国である中国は、2023年から2030年までの分析期間においてCAGR 8.4%で推移し、2030年には3億2,270万米ドルの市場規模に達すると予測されています。その他の注目すべき地域市場としては、日本とカナダがあり、それぞれ2023年から2030年にかけて3.4%と4.4%の成長が予測されています。欧州では、ドイツがCAGR約4.1%で成長すると予測されています。オーストラリア、インド、韓国などの国々が牽引するアジア太平洋地域の市場は、2030年までに2億80万米ドルに達すると予測されています。

2024年の魅力的な新しいレポート機能のご紹介

インフルエンサーのエンゲージメント統計へのフルアクセス

デジタルアーカイブと「MarketGlass」調査プラットフォームへ無料でアクセスできます 。当社独自のMarketGlassプラットフォームは、世界中の専門家の創造性と市場知識を統合的かつ協調的に解き放つことができます。当社の最先端のツールは、市場参入企業のプライバシーとアイデンティティを保護しながら、世界クラスの市場展望をもたらします。レポート内の数字、統計、市場に関する説明は、この分野の専門家や影響力のある人々によって共有された、完全にキュレートされた洞察に基づいています。

リアルタイムのデータシミュレーター・ツールや特注のレポート作成機能を備えたインタラクティブなアンケートに参加できます。

企業間のスマートな意見交換のためのピアコラボレーティブ・インタラクティブプラットフォームへのフルクライアントアクセス

1年間の無料レポート更新

主要企業の世界市場シェアを含む競合カバレッジ

複数の地域にまたがる企業の市場プレゼンス分析(好調/活発/ニッチ/マイナー)

専門家/インフルエンサーのインタビュー、ポッドキャスト、報道発表、イベント基調講演のYouTubeビデオへのアクセス

2024年の世界経済に期待すること

金融引き締めとそれに伴う金利上昇によって引き起こされる地政学的、経済的不安定性が、2024年の激動の情勢を作り出すと見込まれます。中東での敵対行為や、ますます頻発する気候災害など、いくつかの要因が回復への道筋に圧力をかけ続けると思われます。リスクの一方で、ディスインフレの兆候が強まり、頑迷なインフレに対する不安が緩和され、サプライチェーンが正常化し、エネルギーコストの変動にもかかわらず物価が緩やかになるなど、いくつかのプラス材料も具体化しつつあります。インドや米国をはじめとするG21諸国の選挙は、資本の流れや投資戦略に影響を与える可能性があります。インドが世界な投資先として注目される一方で、米国を拠点とするハイテク企業は、才能と資本のダイナミックなエコシステムに後押しされ、引き続き優位を保つと思われます。シリコンバレーをはじめとするハイテク機会は、国内経済が減速しているとはいえ底堅く、規制環境も整備されていることから、高成長の可能性を求める投資家にとって引き続き魅力的です。欧州は金融引き締め政策と景気後退リスクとの戦いが続きますが、英国は見通しが最も厳しく、2024年の景気後退リスクが最も高くなります。中国は、政府支出と個人消費の改善に支えられた成長が期待されるもの、引き続きワイルドカードとなります。不安定な環境は、投資家にも企業にもチャンスと課題の両方をもたらすと思われます。成長への触媒としてボラティリティを受け入れるとともに、敏捷性と戦略的な先見性をもって投資判断に臨むことが、生き残りのために重要であることに変わりありません。

調査対象企業の例(全42件)

  • Anthrex
  • Bioventus LLC
  • Bone Biologics, Corp.
  • DePuy Synthes, Inc.
  • Genzyme
  • Globus Medical
  • Medtronic
  • NuVasive, Inc.
  • Orthofix, Inc.
  • Osiris Therapeutics, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP17325

Global Synthetic Orthobiologics Market to Reach $1.4 Billion by 2030

The global market for Synthetic Orthobiologics estimated at US$980.6 Million in the year 2023, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Osteoarthritis & Degenerative Arthritis Application, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$456.2 Million by the end of the analysis period. Growth in the Fracture Recovery Application segment is estimated at 5.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $257.6 Million, While China is Forecast to Grow at 8.4% CAGR

The Synthetic Orthobiologics market in the U.S. is estimated at US$257.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$322.7 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 4.4% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$200.8 Million by the year 2030.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 42 Featured) -

  • Anthrex
  • Bioventus LLC
  • Bone Biologics, Corp.
  • DePuy Synthes, Inc.
  • Genzyme
  • Globus Medical
  • Medtronic
  • NuVasive, Inc.
  • Orthofix, Inc.
  • Osiris Therapeutics, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Synthetic Orthobiologics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Synthetic Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Synthetic Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Osteoarthritis & Degenerative Arthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Osteoarthritis & Degenerative Arthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Osteoarthritis & Degenerative Arthritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Fracture Recovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Fracture Recovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Fracture Recovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Spinal Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Spinal Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Spinal Fusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Soft Tissue Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Soft Tissue Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Soft Tissue Injuries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Synthetic Orthobiologics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Synthetic Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Synthetic Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Japan 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Synthetic Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: China 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Synthetic Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Synthetic Orthobiologics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Synthetic Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Europe 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Synthetic Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: France 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Synthetic Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Germany 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Italy 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Synthetic Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: UK 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Spain 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Russia 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Rest of Europe 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Synthetic Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Synthetic Orthobiologics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Synthetic Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Asia-Pacific 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Synthetic Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Australia 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Synthetic Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: India 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: South Korea 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Synthetic Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Synthetic Orthobiologics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for Synthetic Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Latin America 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Argentina 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Brazil 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Mexico 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Latin America 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Synthetic Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Synthetic Orthobiologics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for Synthetic Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Middle East 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Iran 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Israel 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Saudi Arabia 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UAE 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Middle East 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Synthetic Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Synthetic Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Africa 16-Year Perspective for Synthetic Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION